Repro Med Systems (KRMD) Reports In-Line Q1 EPS

Repro Med Systems (NASDAQ: KRMD) reported Q1 EPS of ($0.05), in-line with the analyst estimate of ($0.05). Revenue for the quarter came in at $7.4 million versus the consensus estimate of $7.56 million.

GUIDANCE:

Repro Med Systems sees FY2023 revenue of $32.5-33.5 million, versus the consensus of $32.7 million.

For earnings history and earnings-related data on Repro Med Systems (KRMD) click here.

You May Also Be Interested In

• Sprinklr (CXM) Tops Q2 EPS by 1c, Offers Guidance
• Yatsen Holding (YSG) Reports Q2 Loss of $0.16
• Redburn starts Mettler-Toledo at Sell, sees valuation outpacing growth